ClinicalTrials.Veeva

Menu

Effects of Different Crystalloid Solutions for Extra-corporeal Membrane Oxygenator (ECMO) Priming

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Unknown

Conditions

Acute Respiratory Failure

Treatments

Other: Priming of ECMO circuit with 0.9% NaCl
Other: Priming of ECMO circuit with Balanced Solution
Other: Priming of ECMO circuit with Ringer Lactate

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Crystalloid solutions modify acid-base equilibrium according to their electrolyte composition. Moreover, it has been suggested that these alterations are generated by the difference between the solution strong ion difference (SID) and the plasma bicarbonate level. An increased risk of acute kidney injury and renal replacement therapy has been associated to the infusion of chloride rich crystalloids. This study aims to compare, in patients with acute respiratory failure undergoing ECMO support, the effects on acid-base status and renal function of crystalloids commonly employed for circuit priming to a balanced solution created with a SID equal to patients' bicarbonate level.

Enrollment

45 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Acute Respiratory Failure in need for ECMO treatment

Exclusion criteria

  • None

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 3 patient groups

0.9% NaCl
Active Comparator group
Description:
Circuit priming will be performed with 0.9% NaCl solution
Treatment:
Other: Priming of ECMO circuit with 0.9% NaCl
Ringer Lactate
Active Comparator group
Description:
Circuit priming will be performed with Ringer Lactated
Treatment:
Other: Priming of ECMO circuit with Ringer Lactate
Balanced Solution
Experimental group
Description:
Circuit priming will be performed with a Balanced Solution created by mixing 0.9% NaCl, Sodium bicarbonate (8.4%) and injectable sterile water, in order to obtain a solution with constant sodium concentration (140 mEq/l) and SID equal to patient's bicarbonate level.
Treatment:
Other: Priming of ECMO circuit with Balanced Solution

Trial contacts and locations

1

Loading...

Central trial contact

Pietro Caironi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems